心肌梗死的二级预防：乙酰水杨酸、安慰剂和苯丙香豆素的比较 - Suppr

Suppr

超能文献

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.

作者信息

Breddin K, Loew D, Lechner K, Uberla K, Walter E

出版信息

Haemostasis. 1980;9(6):325-44. doi: 10.1159/000214375.

DOI:10.1159/000214375

PMID:7005035

Abstract

摘要

相似文献

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.心肌梗死的二级预防：乙酰水杨酸、安慰剂和苯丙香豆素的比较

Haemostasis. 1980;9(6):325-44. doi: 10.1159/000214375.

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.德奥阿司匹林试验：乙酰水杨酸、安慰剂和苯丙香豆素在心肌梗死二级预防中的比较。代表德奥研究小组。

Circulation. 1980 Dec;62(6 Pt 2):V63-72.

[Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].

Verh Dtsch Ges Inn Med. 1980;86:1338-48.

Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.心肌梗死的二级预防。乙酰水杨酸、苯丙香豆素与安慰剂的比较。一项多中心两年前瞻性研究。

Thromb Haemost. 1979 Feb 28;41(1):225-36.

[Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].

Verh Dtsch Ges Inn Med. 1978(84):1481-5.

[Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].

Verh Dtsch Ges Inn Med. 1977;83:1731-5.

[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].

Dtsch Med Wochenschr. 1981 Apr 24;106(17):546-53. doi: 10.1055/s-2008-1070354.

Secondary prevention of myocardial infarction.心肌梗死的二级预防

Int J Clin Pharmacol Res. 1985;5(5):303-7.

Interaction of allopurinol with phenprocoumon in man.

Klin Wochenschr. 1977 Aug 1;55(15):759-61. doi: 10.1007/BF01476963.

E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.

Scand J Haematol Suppl. 1981;38:47-72.

引用本文的文献

Plasminogen activators and ischemic stroke: conditions for acute delivery.纤溶酶原激活物与缺血性脑卒中：急性给药的条件。

Semin Thromb Hemost. 2013 Jun;39(4):406-25. doi: 10.1055/s-0033-1338126. Epub 2013 Mar 28.

Aspirin in patients with coronary artery disease: is it simply irresistible?阿司匹林用于冠状动脉疾病患者：它是否仅仅是不可抗拒的？

J Thromb Thrombolysis. 2001 Apr;11(2):117-26. doi: 10.1023/a:1011220615447.

Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate.赖氨酸阿司匹林对缺血事件二级预防的经济学评估。

Pharmacoeconomics. 2000 Aug;18(2):185-200. doi: 10.2165/00019053-200018020-00008.

Platelets, aspirin, and cardiovascular disease.血小板、阿司匹林与心血管疾病。

Postgrad Med J. 1998 Oct;74(876):587-91. doi: 10.1136/pgmj.74.876.587.

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.英格兰北部循证指南制定项目：初级保健中阿司匹林用于血管疾病二级预防的指南。英格兰北部阿司匹林指南制定小组。

BMJ. 1998 Apr 25;316(7140):1303-9. doi: 10.1136/bmj.316.7140.1303.

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.阿司匹林的胃肠道毒性：随机对照试验综述

Br J Clin Pharmacol. 1993 Mar;35(3):219-26. doi: 10.1111/j.1365-2125.1993.tb05689.x.

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。

BMJ. 1994 Jan 8;308(6921):81-106.

Prophylactic aspirin and risk of peptic ulcer bleeding.预防性阿司匹林与消化性溃疡出血风险

BMJ. 1995 Apr 1;310(6983):827-30. doi: 10.1136/bmj.310.6983.827.

Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.速释和缓释制剂中乙酰水杨酸和水杨酸的生物利用度，以及与双嘧达莫联合使用时的生物利用度。

Eur J Clin Pharmacol. 1982;22(4):309-14. doi: 10.1007/BF00548398.

[Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy].

Klin Wochenschr. 1983 Mar 15;61(6):297-302. doi: 10.1007/BF01497779.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验